Valérie Bayard, LL.M.
Associate | Attorney at law
T. +41 58 510 92 93
valerie.bayard@advestra.ch
vCard
LinkedIn
Valérie Bayard advises clients on capital market transactions, as well as on regulatory matters. One of her main areas of practice is assisting banks and issuers in the context of IPOs, capital increases and various securities law matters.
She also advises financial services providers on compliance with their regulatory duties. Furthermore, Valérie assists companies on M&A and financing transactions and advises clients in general corporate and contract law matters.
Capital Markets
- Advising Swiss Prime Site on the placement of convertible loan notes
- Advising Lonza on the Placement of bonds
- Advising Goldman Sachs, Jefferies and ZKB on the rights offering by Meyer Burger
- Advising Xlife Sciences, the first equity issuer on the SIX Swiss Exchange Sparks segment
- Advising Credit Suisse and UBS on the IPO of SKAN
- Advising Morgan Stanley, UBS and Zürcher Kantonalbank on the placement of shares of Bachem Holding
- Advising Bank of America Merrill Lynch, J.P. Morgan, UBS und Société Générale on the placement of shares of Adecco Group
Corporate|M&A
- Advising Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals
- Advising Monte Valle Partners on the acquisition of TradeXBank Ltd.
- Advising SIG Combibloc on the acquisition of Pactiv Evergreen's fresh carton business in Asia
- Associate at Advestra (since 2021)
- Admitted to the Bar of the canton of Zurich (2021)
- Junior associate at a leading Swiss law firm (2018–2020)
- LL.M. at Leiden University (2018)
- Junior Risk Manager for a major Swiss Bank (2017)
- Trainee with the General Counsel of a major Swiss Bank (2016)
- MLaw at University of Zurich (2016)
- BLaw at University of Zurich (2015)
- Zurich Bar Association (ZAV)
- Leiden University Alumni
- Shareholder Activism in Switzerland, in Lexology Getting The Deal Through Swiss 2023 M&A Practice Guide (with Rashid Bahar and Valérie Bayard)
- Shareholder Activism in Switzerland, in Lexology Getting The Deal Through Swiss 2022 M&A Practice Guide (with Rashid Bahar and Annette Weber)
- German
- English
- Italian
- All Swiss Courts
- Advestra advises UBS, Bank of America, Zürcher Kantonalbank and the other members of the banking syndicate on DocMorris' rights offering
- Advestra advises Banque Cantonale de Genève on its inaugural EUR-Bonds of EUR 500 million
- Advestra advised Sandoz on the combined issuance of EUR 500 million bonds and CHF 400 million bonds in aggregate
- Advestra advises Galderma on its inaugural EUR 500 Million bonds and its Dual Tranche of CHF 435 Million bonds
- Advestra advises SIG Group on the placement of EUR Bonds in the amount of EUR 625 million
- Advestra advises on the IPO of BioVersys
- Advestra advises Swiss Re on the sale of iptiQ's European Property and Casualty insurance business to Allianz Direct
- Advestra advises Galderma on its inaugural bonds in the aggregate principal amount of CHF 500 million
- Advestra advises Verium on its investment in Lynus
- Advestra advises Novartis on the issuance of CHF 2.2 billion bonds